Anchor name,Anchor target,Anchor pathway,Lib name,Lib target,Lib pathway,Link
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1073
5-Fluorouracil,Antimetabolite (DNA & RNA),Other,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1073
AZD7762,"CHEK1, CHEK2",Cell cycle,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1022
AZD7762,"CHEK1, CHEK2",Cell cycle,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1022
Cisplatin,DNA crosslinker,DNA replication,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1005
Cisplatin,DNA crosslinker,DNA replication,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1005
Cisplatin,DNA crosslinker,DNA replication,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1005
Cisplatin,DNA crosslinker,DNA replication,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1005
Cisplatin,DNA crosslinker,DNA replication,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1005
Cisplatin,DNA crosslinker,DNA replication,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1005
Cisplatin,DNA crosslinker,DNA replication,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1005
Cisplatin,DNA crosslinker,DNA replication,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1005
Cisplatin,DNA crosslinker,DNA replication,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1005
Cisplatin,DNA crosslinker,DNA replication,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1005
Cisplatin,DNA crosslinker,DNA replication,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1005
Cisplatin,DNA crosslinker,DNA replication,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1005
Cisplatin,DNA crosslinker,DNA replication,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1005
Cisplatin,DNA crosslinker,DNA replication,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1005
Cisplatin,DNA crosslinker,DNA replication,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1005
Cisplatin,DNA crosslinker,DNA replication,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1005
Cisplatin,DNA crosslinker,DNA replication,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1005
Cisplatin,DNA crosslinker,DNA replication,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1005
Cisplatin,DNA crosslinker,DNA replication,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1005
Cisplatin,DNA crosslinker,DNA replication,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1005
Cisplatin,DNA crosslinker,DNA replication,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1005
Cisplatin,DNA crosslinker,DNA replication,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1005
Cisplatin,DNA crosslinker,DNA replication,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1005
Cisplatin,DNA crosslinker,DNA replication,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1005
Cisplatin,DNA crosslinker,DNA replication,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1005
Crizotinib,"MET, ALK, ROS1",RTK signaling,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1083
Crizotinib,"MET, ALK, ROS1",RTK signaling,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1083
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1057
Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1057
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1079
Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1079
Erlotinib,EGFR,EGFR signaling,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1168
Erlotinib,EGFR,EGFR signaling,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1168
Erlotinib,EGFR,EGFR signaling,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1168
Erlotinib,EGFR,EGFR signaling,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1168
Erlotinib,EGFR,EGFR signaling,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1168
Erlotinib,EGFR,EGFR signaling,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1168
Erlotinib,EGFR,EGFR signaling,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1168
Erlotinib,EGFR,EGFR signaling,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1168
Erlotinib,EGFR,EGFR signaling,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1168
Erlotinib,EGFR,EGFR signaling,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1168
Erlotinib,EGFR,EGFR signaling,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1168
Erlotinib,EGFR,EGFR signaling,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1168
Erlotinib,EGFR,EGFR signaling,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1168
Erlotinib,EGFR,EGFR signaling,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1168
Erlotinib,EGFR,EGFR signaling,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1168
Erlotinib,EGFR,EGFR signaling,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1168
Erlotinib,EGFR,EGFR signaling,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1168
Erlotinib,EGFR,EGFR signaling,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1168
Erlotinib,EGFR,EGFR signaling,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1168
Erlotinib,EGFR,EGFR signaling,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1168
Erlotinib,EGFR,EGFR signaling,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1168
Erlotinib,EGFR,EGFR signaling,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1168
Erlotinib,EGFR,EGFR signaling,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1168
Erlotinib,EGFR,EGFR signaling,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1168
Erlotinib,EGFR,EGFR signaling,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1168
Galunisertib,TGFBR1,RTK signaling,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+2265
Galunisertib,TGFBR1,RTK signaling,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+2265
Galunisertib,TGFBR1,RTK signaling,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+2265
Galunisertib,TGFBR1,RTK signaling,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+2265
Galunisertib,TGFBR1,RTK signaling,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+2265
Galunisertib,TGFBR1,RTK signaling,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+2265
Galunisertib,TGFBR1,RTK signaling,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+2265
Galunisertib,TGFBR1,RTK signaling,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+2265
Galunisertib,TGFBR1,RTK signaling,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+2265
Galunisertib,TGFBR1,RTK signaling,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+2265
Galunisertib,TGFBR1,RTK signaling,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+2265
Galunisertib,TGFBR1,RTK signaling,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+2265
Galunisertib,TGFBR1,RTK signaling,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+2265
Galunisertib,TGFBR1,RTK signaling,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+2265
Galunisertib,TGFBR1,RTK signaling,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+2265
Galunisertib,TGFBR1,RTK signaling,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+2265
Galunisertib,TGFBR1,RTK signaling,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+2265
Galunisertib,TGFBR1,RTK signaling,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+2265
Galunisertib,TGFBR1,RTK signaling,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+2265
Galunisertib,TGFBR1,RTK signaling,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+2265
Galunisertib,TGFBR1,RTK signaling,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+2265
Galunisertib,TGFBR1,RTK signaling,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+2265
Galunisertib,TGFBR1,RTK signaling,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+2265
Galunisertib,TGFBR1,RTK signaling,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+2265
Galunisertib,TGFBR1,RTK signaling,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+2265
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1190
Gemcitabine,Pyrimidine antimetabolite,DNA replication,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1190
Irinotecan,TOP1,DNA replication,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1088
Irinotecan,TOP1,DNA replication,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1088
Irinotecan,TOP1,DNA replication,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1088
Irinotecan,TOP1,DNA replication,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1088
Irinotecan,TOP1,DNA replication,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1088
Irinotecan,TOP1,DNA replication,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1088
Irinotecan,TOP1,DNA replication,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1088
Irinotecan,TOP1,DNA replication,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1088
Irinotecan,TOP1,DNA replication,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1088
Irinotecan,TOP1,DNA replication,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1088
Irinotecan,TOP1,DNA replication,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1088
Irinotecan,TOP1,DNA replication,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1088
Irinotecan,TOP1,DNA replication,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1088
Irinotecan,TOP1,DNA replication,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1088
Irinotecan,TOP1,DNA replication,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1088
Irinotecan,TOP1,DNA replication,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1088
Irinotecan,TOP1,DNA replication,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1088
Irinotecan,TOP1,DNA replication,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1088
Irinotecan,TOP1,DNA replication,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1088
Irinotecan,TOP1,DNA replication,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1088
Irinotecan,TOP1,DNA replication,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1088
Irinotecan,TOP1,DNA replication,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1088
Irinotecan,TOP1,DNA replication,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1088
Irinotecan,TOP1,DNA replication,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1088
Irinotecan,TOP1,DNA replication,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1088
LGK974,PORCN,WNT signaling,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1598
LGK974,PORCN,WNT signaling,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1598
LGK974,PORCN,WNT signaling,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1598
LGK974,PORCN,WNT signaling,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1598
LGK974,PORCN,WNT signaling,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1598
LGK974,PORCN,WNT signaling,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1598
LGK974,PORCN,WNT signaling,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1598
LGK974,PORCN,WNT signaling,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1598
LGK974,PORCN,WNT signaling,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1598
LGK974,PORCN,WNT signaling,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1598
LGK974,PORCN,WNT signaling,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1598
LGK974,PORCN,WNT signaling,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1598
LGK974,PORCN,WNT signaling,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1598
LGK974,PORCN,WNT signaling,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1598
LGK974,PORCN,WNT signaling,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1598
LGK974,PORCN,WNT signaling,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1598
LGK974,PORCN,WNT signaling,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1598
LGK974,PORCN,WNT signaling,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1598
LGK974,PORCN,WNT signaling,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1598
LGK974,PORCN,WNT signaling,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1598
LGK974,PORCN,WNT signaling,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1598
LGK974,PORCN,WNT signaling,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1598
LGK974,PORCN,WNT signaling,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1598
LGK974,PORCN,WNT signaling,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1598
LGK974,PORCN,WNT signaling,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1598
Lapatinib,"EGFR, ERBB2",EGFR signaling,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1558
Lapatinib,"EGFR, ERBB2",EGFR signaling,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1558
Linsitinib,IGF1R,IGF1R signaling,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1510
Linsitinib,IGF1R,IGF1R signaling,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1510
Linsitinib,IGF1R,IGF1R signaling,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1510
Linsitinib,IGF1R,IGF1R signaling,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1510
Linsitinib,IGF1R,IGF1R signaling,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1510
Linsitinib,IGF1R,IGF1R signaling,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1510
Linsitinib,IGF1R,IGF1R signaling,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1510
Linsitinib,IGF1R,IGF1R signaling,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1510
Linsitinib,IGF1R,IGF1R signaling,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1510
Linsitinib,IGF1R,IGF1R signaling,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1510
Linsitinib,IGF1R,IGF1R signaling,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1510
Linsitinib,IGF1R,IGF1R signaling,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1510
Linsitinib,IGF1R,IGF1R signaling,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1510
Linsitinib,IGF1R,IGF1R signaling,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1510
Linsitinib,IGF1R,IGF1R signaling,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1510
Linsitinib,IGF1R,IGF1R signaling,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1510
Linsitinib,IGF1R,IGF1R signaling,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1510
Linsitinib,IGF1R,IGF1R signaling,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1510
Linsitinib,IGF1R,IGF1R signaling,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1510
Linsitinib,IGF1R,IGF1R signaling,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1510
Linsitinib,IGF1R,IGF1R signaling,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1510
Linsitinib,IGF1R,IGF1R signaling,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1510
Linsitinib,IGF1R,IGF1R signaling,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1510
Linsitinib,IGF1R,IGF1R signaling,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1510
Linsitinib,IGF1R,IGF1R signaling,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1510
MK-1775,"WEE1, PLK1",Cell cycle,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1179
MK-1775,"WEE1, PLK1",Cell cycle,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1179
MK-1775,"WEE1, PLK1",Cell cycle,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1179
MK-1775,"WEE1, PLK1",Cell cycle,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1179
MK-1775,"WEE1, PLK1",Cell cycle,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1179
MK-1775,"WEE1, PLK1",Cell cycle,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1179
MK-1775,"WEE1, PLK1",Cell cycle,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1179
MK-1775,"WEE1, PLK1",Cell cycle,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1179
MK-1775,"WEE1, PLK1",Cell cycle,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1179
MK-1775,"WEE1, PLK1",Cell cycle,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1179
MK-1775,"WEE1, PLK1",Cell cycle,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1179
MK-1775,"WEE1, PLK1",Cell cycle,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1179
MK-1775,"WEE1, PLK1",Cell cycle,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1179
MK-1775,"WEE1, PLK1",Cell cycle,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1179
MK-1775,"WEE1, PLK1",Cell cycle,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1179
MK-1775,"WEE1, PLK1",Cell cycle,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1179
MK-1775,"WEE1, PLK1",Cell cycle,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1179
MK-1775,"WEE1, PLK1",Cell cycle,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1179
MK-1775,"WEE1, PLK1",Cell cycle,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1179
MK-1775,"WEE1, PLK1",Cell cycle,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1179
MK-1775,"WEE1, PLK1",Cell cycle,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1179
MK-1775,"WEE1, PLK1",Cell cycle,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1179
MK-1775,"WEE1, PLK1",Cell cycle,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1179
MK-1775,"WEE1, PLK1",Cell cycle,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1179
MK-1775,"WEE1, PLK1",Cell cycle,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1179
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1053
MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1053
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1011
Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1011
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1594
OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1594
Olaparib,"PARP1, PARP2",Genome integrity,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1017
Olaparib,"PARP1, PARP2",Genome integrity,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1017
Olaparib,"PARP1, PARP2",Genome integrity,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1017
Olaparib,"PARP1, PARP2",Genome integrity,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1017
Olaparib,"PARP1, PARP2",Genome integrity,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1017
Olaparib,"PARP1, PARP2",Genome integrity,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1017
Olaparib,"PARP1, PARP2",Genome integrity,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1017
Olaparib,"PARP1, PARP2",Genome integrity,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1017
Olaparib,"PARP1, PARP2",Genome integrity,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1017
Olaparib,"PARP1, PARP2",Genome integrity,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1017
Olaparib,"PARP1, PARP2",Genome integrity,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1017
Olaparib,"PARP1, PARP2",Genome integrity,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1017
Olaparib,"PARP1, PARP2",Genome integrity,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1017
Olaparib,"PARP1, PARP2",Genome integrity,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1017
Olaparib,"PARP1, PARP2",Genome integrity,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1017
Olaparib,"PARP1, PARP2",Genome integrity,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1017
Olaparib,"PARP1, PARP2",Genome integrity,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1017
Olaparib,"PARP1, PARP2",Genome integrity,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1017
Olaparib,"PARP1, PARP2",Genome integrity,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1017
Olaparib,"PARP1, PARP2",Genome integrity,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1017
Olaparib,"PARP1, PARP2",Genome integrity,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1017
Olaparib,"PARP1, PARP2",Genome integrity,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1017
Olaparib,"PARP1, PARP2",Genome integrity,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1017
Olaparib,"PARP1, PARP2",Genome integrity,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1017
Olaparib,"PARP1, PARP2",Genome integrity,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1017
Oxaliplatin,DNA alkylating agent,DNA replication,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1089
Oxaliplatin,DNA alkylating agent,DNA replication,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1089
Oxaliplatin,DNA alkylating agent,DNA replication,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1089
Oxaliplatin,DNA alkylating agent,DNA replication,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1089
Oxaliplatin,DNA alkylating agent,DNA replication,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1089
Oxaliplatin,DNA alkylating agent,DNA replication,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1089
Oxaliplatin,DNA alkylating agent,DNA replication,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1089
Oxaliplatin,DNA alkylating agent,DNA replication,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1089
Oxaliplatin,DNA alkylating agent,DNA replication,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1089
Paclitaxel,Microtubule stabiliser,Mitosis,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1080
Paclitaxel,Microtubule stabiliser,Mitosis,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1080
Paclitaxel,Microtubule stabiliser,Mitosis,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1080
Paclitaxel,Microtubule stabiliser,Mitosis,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1080
Paclitaxel,Microtubule stabiliser,Mitosis,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1080
Paclitaxel,Microtubule stabiliser,Mitosis,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1080
Paclitaxel,Microtubule stabiliser,Mitosis,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1080
Paclitaxel,Microtubule stabiliser,Mitosis,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1080
Paclitaxel,Microtubule stabiliser,Mitosis,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1080
Palbociclib,"CDK4, CDK6",Cell cycle,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1054
Palbociclib,"CDK4, CDK6",Cell cycle,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1054
Palbociclib,"CDK4, CDK6",Cell cycle,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1054
Palbociclib,"CDK4, CDK6",Cell cycle,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1054
Palbociclib,"CDK4, CDK6",Cell cycle,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1054
Palbociclib,"CDK4, CDK6",Cell cycle,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1054
Palbociclib,"CDK4, CDK6",Cell cycle,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1054
Palbociclib,"CDK4, CDK6",Cell cycle,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1054
Palbociclib,"CDK4, CDK6",Cell cycle,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1054
Ruxolitinib,"JAK1, JAK2","Other, kinases",Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1507
Ruxolitinib,"JAK1, JAK2","Other, kinases",Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1507
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1564
SCH772984,"ERK1, ERK2",ERK MAPK signaling,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1564
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1085
Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1085
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Trametinib,"MEK1, MEK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1372+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1561
Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1561
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Cisplatin,DNA crosslinker,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1005+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Navitoclax,"BCL2, BCL-XL, BCL-W",Apoptosis regulation,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1011+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Olaparib,"PARP1, PARP2",Genome integrity,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1017+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,AZD7762,"CHEK1, CHEK2",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1022+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,MK-2206,"AKT1, AKT2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1053+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Palbociclib,"CDK4, CDK6",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1054+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Dactolisib,"PI3K (class 1), MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1057+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,5-Fluorouracil,Antimetabolite (DNA & RNA),Other,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1073+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Dasatinib,"ABL, SRC, Ephrins, PDGFR, KIT","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1079+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Paclitaxel,Microtubule stabiliser,Mitosis,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1080+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Crizotinib,"MET, ALK, ROS1",RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1083+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Sorafenib,"PDGFR, KIT, VEGFR, RAF","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1085+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Irinotecan,TOP1,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1088+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Oxaliplatin,DNA alkylating agent,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1089+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Erlotinib,EGFR,EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1168+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,MK-1775,"WEE1, PLK1",Cell cycle,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1179+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Gemcitabine,Pyrimidine antimetabolite,DNA replication,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1190+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Ruxolitinib,"JAK1, JAK2","Other, kinases",https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1507+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Linsitinib,IGF1R,IGF1R signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1510+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Lapatinib,"EGFR, ERBB2",EGFR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1558+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Taselisib,PI3K (beta sparing),PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1561+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,SCH772984,"ERK1, ERK2",ERK MAPK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1564+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,OSI-027,"MTORC1, MTORC2",PI3K/MTOR signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1594+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,LGK974,PORCN,WNT signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/1598+1372
Trametinib,"MEK1, MEK2",ERK MAPK signaling,Galunisertib,TGFBR1,RTK signaling,https://gdsc-combinations.depmap.sanger.ac.uk/project/pancreas/combination/2265+1372
